ASTRAZENECA PLC (AZN)
Clinical trial NCT05221840: primary completion date: 2026-06-30 → 2026-09-30.
Clinical trial NCT05221840: primary completion date: 2026-06-30 → 2026-09-30.
Clinical trial NCT07563894 updates: 1. status: RECRUITING → ACTIVE_NOT_RECRUITING 2. enrollment type: ESTIMATED → ACTUAL
Clinical trial NCT07221253 updates: 1. completion date: 2029-07-04 → 2029-07-31 2. primary completion date: 2029-07-04 → 2029-07-31
Clinical trial NCT07218393 updates: 1. start date: 2026-05-01 → 2026-12-01 2. completion date: 2026-12-01 → 2027-12-01 3. primary completion date: 2026-12-01 → 2027-12-01
Clinical trial NCT03299309: completion date: 2026-04-01 → 2027-05-01.
Clinical trial NCT04623775 updates: 1. status: ACTIVE_NOT_RECRUITING → COMPLETED 2. completion date: 2026-02-27 → 2026-05-06
Clinical trial NCT07251933 updates: 1. completion date: 2026-05-29 → 2026-06-30 2. primary completion date: 2026-05-29 → 2026-06-30
Clinical trial NCT07153055 updates: 1. status: NOT_YET_RECRUITING → RECRUITING 2. start date: 2026-05-01 → 2026-08-01
Clinical trial NCT07578636: start date: 2026-05-15 → 2026-06-01.
Clinical trial NCT07278336: enrollment: 207 → 219 participants.